Surgical Treatment of an Intracranial Epidermoid Cyst in a Dog
Journal Article
De Decker, S., Davies, E. S. S., Benigni, L., Wilson, H. E., Pelligand, L., Rayner, E. L., …Volk, H. A. Surgical Treatment of an Intracranial Epidermoid Cyst in a Dog. Veterinary Surgery, 41(6), 766-771. https://doi.org/10.1111/j.1532-950X.2012.01010.x
Outputs (79)
GFR MEASUREMENTS IN FELINE SUBJECTS USING HIGH PERFORMANCE CAPILLARY ELECTROPHORESIS
Journal Article
Devanur, L., Pelligand, L., Hassard, S., & Elliott, J. GFR MEASUREMENTS IN FELINE SUBJECTS USING HIGH PERFORMANCE CAPILLARY ELECTROPHORESIS. Journal of Veterinary Pharmacology and Therapeutics, 35, 174-174
CISPLATIN-INDUCED EMESIS IN DOGS: EVALUATION OF ARGININE VASOPRESSIN AND CORTISOL AS BIOMARKERS OF NAUSEA
Journal Article
Kenward, H., Pelligand, L., Tattersall, F. D., Savary-Bataille, K., & Elliott, J. CISPLATIN-INDUCED EMESIS IN DOGS: EVALUATION OF ARGININE VASOPRESSIN AND CORTISOL AS BIOMARKERS OF NAUSEA. Journal of Veterinary Pharmacology and Therapeutics, 35, 32-33
THE NEXT GENERATION THERAPEUTICS FOR VETERINARY ANALGESIA
Journal Article
Pelligand, L. THE NEXT GENERATION THERAPEUTICS FOR VETERINARY ANALGESIA. Journal of Veterinary Pharmacology and Therapeutics, 35, 55-55
Development and validation of a tissue cage model of acute inflammation in the cat
Journal Article
Pelligand, L., House, A. K., Summers, B. A., Hatzis, A., Tivers, M. S., Elliott, J., & Lees, P. Development and validation of a tissue cage model of acute inflammation in the cat. Journal of Veterinary Pharmacology and Therapeutics, 35(3), 239-248. https://doi.org/10.1111/j.1365-2885.2011.01308.x
PHARMACOKINETICS AND PHARMACOKINETIC/PHARMACODYNAMIC MODELLING OF ROBENACOXIB AND KETOPROFEN IN A CARRAGEENAN-INDUCED INFLAMMATION MODEL IN THE CAT
Journal Article
Pelligand, L., King, J. N., Hormazabal, V., Toutain, P. L., Elliott, J., & Lees, P. PHARMACOKINETICS AND PHARMACOKINETIC/PHARMACODYNAMIC MODELLING OF ROBENACOXIB AND KETOPROFEN IN A CARRAGEENAN-INDUCED INFLAMMATION MODEL IN THE CAT. Journal of Veterinary Pharmacology and Therapeutics, 35, 56-57
Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation
Journal Article
Pelligand, L., King, J. N., Toutain, P. L., Elliott, J., & Lees, P. Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation. Journal of Veterinary Pharmacology and Therapeutics, 35(1), 19-32. https://doi.org/10.1111/j.1365-2885.2011.01288.x
Development and validation of a timed urinary collection system for use in the cat.
Journal Article
Pelligand, L., Lees, P., & Elliott, J. Development and validation of a timed urinary collection system for use in the cat. Laboratory Animals, 45(3), 196-203. https://doi.org/10.1258/la.2011.010153
PK-PD INTEGRATION AND PK-PD MODELLING OF PREFERENTIAL AND SELECTIVE COX-2 INHIBITORS: TOWARDS SAFER DRUGS AND IMPROVED DOSAGE REGIMENS
Journal Article
Lees, P., Giraudel, J., Toutain, P. L., Pelligand, L., & King, J. N. PK-PD INTEGRATION AND PK-PD MODELLING OF PREFERENTIAL AND SELECTIVE COX-2 INHIBITORS: TOWARDS SAFER DRUGS AND IMPROVED DOSAGE REGIMENS. Journal of Veterinary Pharmacology and Therapeutics, 32, 33-36
IN VIVO COX-2 SELECTIVITY OF ROBENACOXIB IN A FELINE TISSUE CAGE MODEL OF INFLAMMATION
Journal Article
Pelligand, L., King, J. N., Toutain, P. L., & Lees, P. IN VIVO COX-2 SELECTIVITY OF ROBENACOXIB IN A FELINE TISSUE CAGE MODEL OF INFLAMMATION. Journal of Veterinary Pharmacology and Therapeutics, 32, 103-104